Historically, abstinence-based recovery has sought to establish that recovering addicts abstain from all use of illicit substances including alcohol. This model of treatment was originally rooted in the Alcoholics Anonymous 12 Step Program which by design was intended to address alcohol addiction specifically. That program has been extremely popular and effective in helping alcohol dependent

Probuphine is a new drug recently developed and released by Braeburn Pharmaceuticals. The drug is FDA-approved and is a time-released version of buprenorphine (the active ingredient in Suboxone that staves off opioid withdrawal symtoms). Probuphine must be implanted beneath the patient’s skin (typically in the arm) where it gradually distributes medication for 6 months. The

A March 2016 Medscape article profiles the rising problem that U.S hospitals are facing as larger numbers of opioid addicted people seek emergency room help. Hospital professionals are witnessing that many who present for help are just not ready to stop opioid misuse. In regard to injecting water-soluble drugs, Dr. Theisen-Toupal of the VA Medical

There is an interesting blog post by Dr. Jana Burson in which she discusses a recent study in the Journal of the American Medical Association (JAMA). The study occurred in the state of Connecticut, and it centered on providing patients a 3-day supply of buprenorphine when they presented in the ER and were found to